Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 149,038,096
  • Shares Outstanding, K 5,662,542
  • Annual Sales, $ 58,496 M
  • Annual Income, $ 2,119 M
  • 60-Month Beta 0.61
  • Price/Sales 2.54
  • Price/Cash Flow 8.74
  • Price/Book 1.64
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 28.89% ( +0.77%)
  • Historical Volatility 14.37%
  • IV Percentile 81%
  • IV Rank 68.34%
  • IV High 33.73% on 10/27/23
  • IV Low 18.44% on 06/09/23
  • Put/Call Vol Ratio 1.00
  • Today's Volume 48,281
  • Volume Avg (30-Day) 149,206
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 3,103,519
  • Open Int (30-Day) 3,000,797

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.56
  • Number of Estimates 8
  • High Estimate 0.82
  • Low Estimate 0.40
  • Prior Year 1.23
  • Growth Rate Est. (year over year) -54.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.23 +3.79%
on 04/18/24
28.12 -6.88%
on 03/28/24
-1.18 (-4.29%)
since 03/22/24
3-Month
25.23 +3.79%
on 04/18/24
28.69 -8.73%
on 03/13/24
-2.15 (-7.57%)
since 01/24/24
52-Week
25.23 +3.79%
on 04/18/24
40.37 -35.13%
on 06/13/23
-13.73 (-34.39%)
since 04/24/23

Most Recent Stories

More News
VELSIPITYâ„¢ Receives Health Canada Approval for Adults with Moderately to Severely Active Ulcerative Colitis (UC)

/CNW/ - Today, Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for VELSIPITYâ„¢. A once-daily oral treatment, VELSIPITY is...

PFE : 26.22 (-0.38%)
Better Buy: Pfizer vs. Viking Therapeutics

These two pharma stocks have followed distinct paths of late. Which is the better investment?

LLY : 730.54 (-2.03%)
NVO : 125.54 (-2.41%)
NVDA : 807.22 (-2.06%)
AMGN : 274.07 (+0.19%)
PFE : 26.22 (-0.38%)
VKTX : 65.05 (+0.18%)
1 No-Brainer Vanguard Fund to Buy Right Now

This Vanguard growth fund is home to some of the world's most innovative companies.

VOO : 462.68 (-0.46%)
META : 489.30 (-1.37%)
MSFT : 407.00 (-0.14%)
AAPL : 168.14 (+0.74%)
AMZN : 176.38 (-1.76%)
NVDA : 807.22 (-2.06%)
AMGN : 274.07 (+0.19%)
ADBE : 475.10 (+0.47%)
VKTX : 65.05 (+0.18%)
PFE : 26.22 (-0.38%)
ANET : 252.10 (+0.37%)
PLTR : 21.45 (-0.88%)
Pfizer Canada and McMaster University to foster health equity in vaccine science

/CNW/ - During National Immunization Awareness Week, Pfizer Canada and McMaster University are proud to announce a significant project aimed at addressing...

PFE : 26.22 (-0.38%)
3 Stocks Under $50 You Can Buy Hand Over Fist Right Now

A little up-front investment can go a long way with these three stocks.

NVDA : 807.22 (-2.06%)
AMD : 151.08 (-0.78%)
EPD : 28.76 (-0.52%)
INTC : 34.56 (+0.82%)
PFE : 26.22 (-0.38%)
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today

The answer to that question will either make you wince or smile.

PFE : 26.22 (-0.38%)
3 No-Brainer Stocks to Buy With $100 Right Now

A modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.

COMP : 3.33 (-2.35%)
PFE : 26.22 (-0.38%)
PM : 97.74 (+0.08%)
BIDU : 98.40 (+0.17%)
World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"

/CNW/ - On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is...

PFE : 26.22 (-0.38%)
5 Underperforming Stocks That Look Ready to Rebound, According to Goldman

Analysts at Goldman Sachs think these 5 underperforming stocks could be poised to outperform, thanks to a healthy valuation discount and expected EPS growth.

GS : 421.31 (-0.63%)
$SPX : 5,049.86 (-0.41%)
PFE : 26.22 (-0.38%)
BA : 166.56 (-1.55%)
PANW : 291.93 (-0.53%)
AKAM : 102.17 (+0.40%)
EL : 146.48 (-1.68%)
Better Growth Play: Merck or The Vanguard Growth Index Fund?

Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?

LLY : 730.54 (-2.03%)
PFE : 26.22 (-0.38%)
BMY : 48.78 (-0.43%)
NVO : 125.54 (-2.41%)
GILD : 66.99 (-0.06%)
MRK : 126.44 (-0.35%)
VUG : 329.80 (-0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 26.74
2nd Resistance Point 26.61
1st Resistance Point 26.46
Last Price 26.22
1st Support Level 26.18
2nd Support Level 26.05
3rd Support Level 25.90

See More

52-Week High 40.37
Fibonacci 61.8% 34.58
Fibonacci 50% 32.80
Fibonacci 38.2% 31.01
Last Price 26.22
52-Week Low 25.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar